CELGENE CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-07-27
Last Posted Date
2023-09-08
Lead Sponsor
Celgene
Target Recruit Count
15
Registration Number
NCT02509039
Locations
🇯🇵

Local Institution - 003, Chikusa-ku, Japan

🇯🇵

Local Institution - 001, Kashiwa, Japan

🇯🇵

Local Institution - 002, Koto-ku, Tokyo, Japan

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2015-07-20
Last Posted Date
2019-11-18
Lead Sponsor
Celgene
Target Recruit Count
24
Registration Number
NCT02502188
Locations
🇺🇸

PPD Development, LP, Austin, Texas, United States

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2015-07-10
Last Posted Date
2023-12-12
Lead Sponsor
Celgene
Target Recruit Count
4
Registration Number
NCT02494258
Locations
🇬🇧

Manchester Royal Infirmary, Manchester, United Kingdom

🇺🇸

Local Institution - 102, Houston, Texas, United States

🇺🇸

Johns Hopkins Oncology Center, Baltimore, Maryland, United States

A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.

First Posted Date
2015-05-21
Last Posted Date
2019-12-20
Lead Sponsor
Celgene
Target Recruit Count
7
Registration Number
NCT02450877
Locations
🇩🇪

Charite Berlin, Berlin, Germany

🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇩🇪

Universitatsklinikum Essen, Essen, Germany

and more 5 locations

Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)

First Posted Date
2015-05-19
Last Posted Date
2019-07-11
Lead Sponsor
Celgene
Target Recruit Count
28
Registration Number
NCT02447666
Locations
🇧🇪

Hopital Universitaire des Enfants, Brussels, Belgium

🇨🇭

Universitäts-Kinderklinik, Zurich, Switzerland

🇳🇱

Erasmus University Medical Center, Rotterdam, Netherlands

and more 35 locations

Radiolabeled Study of AG-221 in Healthy Male Subjects.

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-05-13
Last Posted Date
2018-10-30
Lead Sponsor
Celgene
Target Recruit Count
8
Registration Number
NCT02443168

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2015-05-06
Last Posted Date
2021-09-01
Lead Sponsor
Celgene
Target Recruit Count
1012
Registration Number
NCT02435992
Locations
🇺🇸

Arizona Digestive Health, Sun City, Arizona, United States

🇺🇸

Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States

🇺🇸

Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States

and more 368 locations

Relative Bioavailability Study of CC-292

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-05-05
Last Posted Date
2020-08-13
Lead Sponsor
Celgene
Target Recruit Count
24
Registration Number
NCT02433457
Locations
🇺🇸

Covance Clinical Research unit, Evansville, Indiana, United States

A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.

First Posted Date
2015-04-15
Last Posted Date
2023-10-23
Lead Sponsor
Celgene
Target Recruit Count
75
Registration Number
NCT02417285
Locations
🇳🇱

Local Institution - 201, Amsterdam, Netherlands

🇳🇱

Local Institution - 202, Rotterdam, Netherlands

🇫🇷

Local Institution - 105, Borddeaux Cedex, France

and more 5 locations

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

First Posted Date
2015-04-02
Last Posted Date
2021-09-20
Lead Sponsor
Celgene
Target Recruit Count
47
Registration Number
NCT02406742
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

🇦🇹

University Hospital of Salzburg St Johanns Spital, Salzburg, Austria

🇺🇸

The West Clinic, Memphis, Tennessee, United States

and more 21 locations
© Copyright 2024. All Rights Reserved by MedPath